Medigen Biotechnology Corp.

TPEX:3176 Stock Report

Market Cap: NT$4.9b

Medigen Biotechnology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Shun-Lang Chang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.3yrs
CEO ownershipn/a
Management average tenure4.6yrs
Board average tenure21.4yrs

Recent management updates

Recent updates

Is Medigen Biotechnology (GTSM:3176) Using Debt Sensibly?

Apr 13
Is Medigen Biotechnology (GTSM:3176) Using Debt Sensibly?

Medigen Biotechnology (GTSM:3176) Shareholders Have Enjoyed A 83% Share Price Gain

Feb 19
Medigen Biotechnology (GTSM:3176) Shareholders Have Enjoyed A 83% Share Price Gain

Does Medigen Biotechnology (GTSM:3176) Have A Healthy Balance Sheet?

Dec 29
Does Medigen Biotechnology (GTSM:3176) Have A Healthy Balance Sheet?

CEO Compensation Analysis

How has Shun-Lang Chang's remuneration changed compared to Medigen Biotechnology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-NT$413m

Jun 30 2024n/an/a

-NT$433m

Mar 31 2024n/an/a

-NT$542m

Dec 31 2023n/an/a

-NT$561m

Sep 30 2023n/an/a

-NT$594m

Jun 30 2023n/an/a

-NT$663m

Mar 31 2023n/an/a

-NT$689m

Dec 31 2022NT$10mNT$3m

-NT$676m

Compensation vs Market: Insufficient data to establish whether Shun-Lang's total compensation is reasonable compared to companies of similar size in the TW market.

Compensation vs Earnings: Insufficient data to compare Shun-Lang's compensation with company performance.


CEO

Shun-Lang Chang

8.3yrs

Tenure

NT$9,810,000

Compensation

Mr. Shun-Lang Chang is General Manager of Medigen Biotechnology Corp. since July 01, 2016. He serves as Director at Cellxpert Biotechnology Co., Ltd. and Director at Medigen Biotechnology Corp. (Beijing)....


Leadership Team

NamePositionTenureCompensationOwnership
Shun-Lang Chang
General Manager8.3yrsNT$9.81mno data
Ya-Ling Chiang
Assistant Vice President of Operations & Management Department5.4yrsNT$3.04mno data
Chin-Yen Chen
Assistant Vice President of Drug Development Departmentno dataNT$2.54mno data
Feng-Hua Chen
Finance Manager & Accounting Officer3.8yrsno datano data
Chieh-Liang Lin
Chief Scientific Officerless than a yearno datano data

4.6yrs

Average Tenure

Experienced Management: 3176's management team is considered experienced (4.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shi-Chung Chang
Chairman21.4yrsno data1.68%
NT$ 81.8m
Por-Hsiung Lai
Independent Director9.4yrsNT$298.00kno data
Tse Ling Chang
Representative Director24.3yrsNT$132.00kno data
Min-Li Chuang
Representative Director23.3yrsNT$138.00k0.31%
NT$ 15.0m
Shang Cai
Supervisorno datano datano data
Dun Hong
Supervisorno datano datano data
Jing Wu
Supervisorno datano datano data
Tzu-Liang Huang
Representative Director23.3yrsNT$138.00k4.57%
NT$ 222.4m
Shui-Ming Chuang
Independent Director6.4yrsNT$298.00kno data
Pei-Wei Chen
Independent Director3.3yrsNT$298.00kno data

21.4yrs

Average Tenure

Experienced Board: 3176's board of directors are seasoned and experienced ( 21.4 years average tenure).